Please try another search
Vilmorin & Cie SA reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was EUR 1,894.4 million compared to EUR 1,587.2 million a year ago. Net income was EUR 93.8 million compared to EUR 92.2 million a year ago. Basic earnings per share from continuing operations was EUR 4.1 compared to EUR 4.02 a year ago. Diluted earnings per share from continuing operations was EUR 4.05 compared to EUR 3.98 a year ago. Basic earnings per share was EUR 4.1 compared to EUR 4.02 a year ago. Diluted earnings per share was EUR 4.05 compared to EUR 3.98 a year ago.
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Revenue | 353.25 | 353.25 | ||
Gross Profit | 182.05 | 182.05 | ||
Operating Income | 86.55 | 86.55 | 10 | 10 |
Net Income | -6.2 | -6.2 |
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Assets | 3778.6 | 3778.6 | ||
Total Liabilities | 2375.1 | 2375.1 | ||
Total Equity | 1403.5 | 1403.5 |
Period Ending: | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -50.35 | -50.35 | ||
Cash From Investing Activities | -62.65 | -62.65 | ||
Cash From Financing Activities | 103.55 | 103.55 | ||
Net Change in Cash | -17.55 | -17.55 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review